UTI Healthcare Fund
Sectoral-PharmaVery HighOPEN-ENDED
- NAV as on 9 Nov 2026
- ₹350.27+2.37%1 day
- Return since launch
- 14.8%
- 52-week range
- ₹268.59 — ₹346.36
- AUM
- ₹1,430 Cr
UTI Healthcare Fund is a Sectoral-Pharma equity fund from UTI Mutual Fund with ₹1,430 Cr under management, launched in 2005. Over three years it has returned 18.4% a year, against 21.2% for its category. The expense ratio is 2.22% and the SEBI riskometer reading is Very High.
Performance
UTI Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +21.3% against +19.9% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 30.6% | +9.8 pts | 20.8% | 29.1% |
| 2Y | 19.1% | +0.1 pts | 19.1% | 17.6% |
| 3Y | 18.4% | −2.8 pts | 21.2% | 16.0% |
| 5Y | 21.1% | +5.6 pts | 15.4% | 18.5% |
| 7Y | 20.0% | +1.2 pts | 18.9% | 18.0% |
| 10Y | 18.7% | +4.2 pts | 14.4% | 17.2% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 7.8% | −0.6 pts | 8.4% | 8.5% |
| 3M | 3.1% | −0.7 pts | 3.7% | 3.7% |
| 6M | 14.9% | +0.9 pts | 14.0% | 13.6% |
| 1Y | 21.0% | +0.2 pts | 20.8% | 19.4% |
| 2Y | 11.1% | +0.2 pts | 10.8% | 9.5% |
| 3Y | 22.7% | +1.5 pts | 21.2% | 20.0% |
| 5Y | 16.2% | +0.8 pts | 15.4% | 14.6% |
| 7Y | 23.2% | +0.9 pts | 22.4% | 21.2% |
| 10Y | 14.5% | 0.0 pts | 14.4% | 13.2% |
Since launch (1 Aug 2005): 14.8%
Calendar-year returns
Category average67.4%
19.1%
-12.3%
38.2%
42.4%
-3.1%
Show as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -3.1% | −1.1 pts | -2.0% |
| 2024 | 42.4% | +1.6 pts | 40.9% |
| 2023 | 38.2% | +2.0 pts | 36.2% |
| 2022 | -12.3% | −4.0 pts | -8.3% |
| 2021 | 19.1% | −2.6 pts | 21.7% |
| 2020 | 67.4% | −1.4 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.21%
Expense ratio as on 6 Nov 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.82%
- Brokerage
- 0.03%
- Transaction charges
- 0.00%
- Statutory levies
- 0.36%
- Exit load
- Exit load of 1% if redeemed within 30 days.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Very High
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | -0.05 | 1.88 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.96 | 0.93 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 1.01 | 1.12 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.66 | 1.85 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 15.99 | 15.52 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 4 category peers | |||
Portfolio
UTI Healthcare Fund portfolio
Portfolio as of 30 Sep 2026
Asset allocation
- Equity94.1%
- Debt0.0%
- Other5.9%
Market cap split
- Large19.4%
- Mid36.8%
- Small43.8%
- P/E
- 40.80
- P/B
- 5.15
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 7.62% | ₹109 Cr | +8.54% | +9.99% | +9.61% |
| Divi's Laboratories Ltd. | Healthcare | 6.15% | ₹88.00 Cr | +4.74% | +3.42% | +2.59% |
| Others | Others | 5.88% | ₹84.02 Cr | +9.90% | +2.64% | +2.03% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 5.24% | ₹74.86 Cr | +3.01% | +3.45% | +3.74% |
| Ajanta Pharma Ltd. | Healthcare | 4.81% | ₹68.80 Cr | +5.08% | +6.40% | +5.48% |
| Gland Pharma Ltd. | Healthcare | 4.06% | ₹57.99 Cr | +4.11% | +3.46% | +3.62% |
| Alkem Laboratories Ltd. | Healthcare | 3.70% | ₹52.93 Cr | +3.14% | +3.41% | +3.56% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 3.03% | ₹43.28 Cr | +3.52% | +3.73% | +3.58% |
| Caplin Point Laboratories Ltd. | Healthcare | 3.02% | ₹43.20 Cr | +4.02% | +2.07% | +2.35% |
| Global Health Ltd. | Healthcare | 2.96% | ₹42.32 Cr | +2.61% | +1.92% | +1.77% |
| Lupin Ltd. | Healthcare | 2.89% | ₹41.38 Cr | +3.77% | +5.92% | +4.70% |
| Ipca Laboratories Ltd. | Healthcare | 2.81% | ₹40.23 Cr | +2.73% | +2.38% | +1.92% |
| Max Healthcare Institute Ltd. | Healthcare | 2.80% | ₹39.98 Cr | +2.98% | +2.63% | +2.44% |
| Cohance Lifesciences Ltd. | Healthcare | 2.79% | ₹39.96 Cr | +2.44% | +2.76% | +2.89% |
| Marksans Pharma Ltd. | Healthcare | 2.25% | ₹32.23 Cr | +2.09% | +1.69% | +1.14% |
| Rainbow Children's Medicare Ltd. | Healthcare | 2.21% | ₹31.54 Cr | +2.06% | +1.59% | +0.97% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 2.12% | ₹30.25 Cr | +2.18% | +4.04% | +3.74% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.09% | ₹29.84 Cr | +1.96% | +2.19% | +3.15% |
| Aurobindo Pharma Ltd. | Healthcare | 2.07% | ₹29.57 Cr | +1.93% | +2.98% | +2.47% |
| Fortis Healthcare Ltd. | Healthcare | 2.02% | ₹28.88 Cr | +2.93% | +3.01% | +3.54% |
| Procter & Gamble Health Ltd. | Healthcare | 1.95% | ₹27.82 Cr | +2.42% | +2.27% | +3.99% |
| Anthem Biosciences Ltd. | Healthcare | 1.80% | ₹25.76 Cr | +2.49% | +2.32% | +1.46% |
| Aster DM Quality Care Ltd. | Healthcare | 1.76% | ₹25.10 Cr | +1.95% | +2.06% | +1.74% |
| Dr. Lal Pathlabs Ltd. | Healthcare | 1.67% | ₹23.88 Cr | +1.26% | +1.24% | — |
| Biocon Ltd. | Healthcare | 1.62% | ₹23.14 Cr | +0.64% | +0.68% | +1.09% |
| Metropolis Healthcare Ltd. | Healthcare | 1.47% | ₹20.96 Cr | +1.60% | +1.59% | +1.80% |
| Windlas Biotech Ltd. | Healthcare | 1.42% | ₹20.29 Cr | +1.22% | +1.16% | +1.33% |
| Cipla Ltd. | Healthcare | 1.41% | ₹20.19 Cr | +1.68% | +1.74% | +5.48% |
| Blue Jet Healthcare Ltd. | Healthcare | 1.41% | ₹20.18 Cr | — | — | — |
| Alembic Pharmaceuticals Ltd. | Healthcare | 1.40% | ₹20.04 Cr | +1.26% | +0.52% | +0.90% |
| Viyash Scientific Limited | Healthcare | 1.39% | ₹19.85 Cr | +2.32% | +1.90% | +1.48% |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 1.33% | ₹19.02 Cr | +1.37% | +1.08% | +1.09% |
| Sudeep Pharma Ltd. | Healthcare | 1.28% | ₹18.33 Cr | +1.72% | +2.14% | — |
| Sai Life Sciences Ltd. | Healthcare | 1.26% | ₹18.01 Cr | +2.17% | +2.11% | +1.80% |
| Eris Lifesciences Ltd. | Healthcare | 1.13% | ₹16.09 Cr | +1.48% | +1.84% | +2.59% |
| Laxmi Dental Ltd. | Healthcare | 1.08% | ₹15.38 Cr | +1.03% | +0.60% | +0.45% |
| Manipal Health Enterprises Ltd. | Healthcare | 1.05% | ₹15.05 Cr | — | — | — |
| Aarti Pharmalabs Ltd. | Services | 1.00% | ₹14.31 Cr | +0.78% | +0.84% | — |
| Pfizer Ltd. | Healthcare | 0.93% | ₹13.30 Cr | +1.17% | +1.72% | +1.77% |
| Orchid Pharma Ltd. | Healthcare | 0.71% | ₹10.11 Cr | +0.75% | +0.46% | +0.64% |
| Sanofi Consumer Healthcare India Ltd. | Healthcare | 0.67% | ₹9.61 Cr | +0.85% | +0.98% | +1.03% |
| Jubilant Pharmova Ltd. | Healthcare | 0.65% | ₹9.23 Cr | +0.67% | +0.69% | +0.88% |
| Indegene Ltd. | Healthcare | 0.50% | ₹7.10 Cr | — | — | — |
| Syngene International Ltd. | Healthcare | 0.42% | ₹5.96 Cr | +0.55% | +0.66% | +1.02% |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.20% | ₹2.91 Cr | +0.97% | +1.05% | +0.88% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. | 3.62% | 5.24% | +1.61% |
| Anthem Biosciences Ltd. | 2.62% | 1.80% | -0.82% |
| Emcure Pharmaceuticals Ltd. | 0.89% | 0.20% | -0.69% |
| Sun Pharmaceutical Industries Ltd. | 8.25% | 7.62% | -0.63% |
| Cohance Lifesciences Ltd. | 2.21% | 2.79% | +0.58% |
| Sai Life Sciences Ltd. | 1.79% | 1.26% | -0.53% |
| Indegene Ltd. | 0.00% | 0.50% | +0.50% |
| Blue Jet Healthcare Ltd. | 0.99% | 1.41% | +0.42% |
| Alkem Laboratories Ltd. | 3.29% | 3.70% | +0.42% |
| Gland Pharma Ltd. | 3.70% | 4.06% | +0.36% |
| Fortis Healthcare Ltd. | 2.36% | 2.02% | -0.34% |
| Max Healthcare Institute Ltd. | 3.10% | 2.80% | -0.31% |
| Alembic Pharmaceuticals Ltd. | 1.16% | 1.40% | +0.24% |
| Apollo Hospitals Enterprise Ltd. | 3.27% | 3.03% | -0.24% |
| Biocon Ltd. | 1.42% | 1.62% | +0.20% |
| Lupin Ltd. | 3.09% | 2.89% | -0.20% |
| Pfizer Ltd. | 1.11% | 0.93% | -0.18% |
| Viyash Scientific Limited | 1.54% | 1.39% | -0.15% |
| Global Health Ltd. | 2.81% | 2.96% | +0.15% |
| Others | 5.71% | 5.85% | +0.15% |
| Sudeep Pharma Ltd. | 1.42% | 1.28% | -0.14% |
| Windlas Biotech Ltd. | 1.28% | 1.42% | +0.14% |
| Aster DM Quality Care Ltd. | 1.89% | 1.76% | -0.13% |
| Aarti Pharmalabs Ltd. | 0.88% | 1.00% | +0.12% |
| Glenmark Pharmaceuticals Ltd. | 2.23% | 2.12% | -0.11% |
| Jubilant Pharmova Ltd. | 0.55% | 0.65% | +0.10% |
| Metropolis Healthcare Ltd. | 1.56% | 1.47% | -0.10% |
| Laxmi Dental Ltd. | 0.98% | 1.08% | +0.09% |
| Eris Lifesciences Ltd. | 1.21% | 1.13% | -0.09% |
| Jupiter Life Line Hospitals Ltd. | 2.17% | 2.09% | -0.08% |
| Ajanta Pharma Ltd. | 4.74% | 4.81% | +0.07% |
| Manipal Health Enterprises Ltd. | 1.12% | 1.05% | -0.07% |
| Vijaya Diagnostic Centre Ltd. | 1.39% | 1.33% | -0.06% |
| Ipca Laboratories Ltd. | 2.87% | 2.81% | -0.06% |
| Dr. Lal Pathlabs Ltd. | 1.61% | 1.67% | +0.06% |
| Divi's Laboratories Ltd. | 6.21% | 6.15% | -0.06% |
| Procter & Gamble Health Ltd. | 2.00% | 1.95% | -0.05% |
| Cipla Ltd. | 1.46% | 1.41% | -0.05% |
| Rainbow Children's Medicare Ltd. | 2.25% | 2.21% | -0.05% |
| Syngene International Ltd. | 0.45% | 0.42% | -0.04% |
| Aurobindo Pharma Ltd. | 2.10% | 2.07% | -0.04% |
| Caplin Point Laboratories Ltd. | 3.05% | 3.02% | -0.03% |
| Marksans Pharma Ltd. | 2.23% | 2.25% | +0.03% |
| Orchid Pharma Ltd. | 0.68% | 0.71% | +0.03% |
| Sanofi Consumer Healthcare India Ltd. | 0.69% | 0.67% | -0.02% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹3,310 Cr | 1.81% | 38.0% | 21.4% | 21.9% |
 SBI Healthcare Opportunities Fund | ₹6,067 Cr | 1.98% | 35.0% | 19.9% | 22.6% |
 HDFC Pharma And Healthcare Fund | ₹3,501 Cr | 2.11% | 39.6% | 25.8% | — |
 Mirae Asset Healthcare Fund | ₹3,494 Cr | 2.01% | 37.3% | 20.2% | 21.1% |
 ICICI Prudential Nifty Pharma Index Fund | ₹177 Cr | 1.13% | 39.9% | 19.9% | — |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Fund managers
- Kamal GadaMr. Gada is B.com, CA, CS, & CFAPrior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
₹
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months14.88% absolute | ₹60,000 | ₹68,928 | 14.88% | |
| 1 year21.01% annualised | ₹1,20,000 | ₹1,34,573 | 12.14% | |
| 3 years22.71% annualised | ₹3,60,000 | ₹5,18,966 | 44.16% | |
| 5 years16.21% annualised | ₹6,00,000 | ₹9,27,998 | 54.67% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.
What is the NAV of UTI Healthcare Fund?
The NAV of UTI Healthcare Fund is ₹350.27 as on 9 Nov 2026.
What is the expense ratio of UTI Healthcare Fund?
The expense ratio of UTI Healthcare Fund is 2.22% per year.
What is the minimum SIP amount for UTI Healthcare Fund?
You can start a SIP in UTI Healthcare Fund with ₹3,000 a month.
What returns has UTI Healthcare Fund given?
UTI Healthcare Fund has returned 30.6% over 1 year, 18.4% over 3 years and 21.1% over 5 years (annualised).
Is there a lock-in or exit load on UTI Healthcare Fund?
Lock-in: None. Exit load: Exit load of 1% if redeemed within 30 days..
How risky is UTI Healthcare Fund?
UTI Healthcare Fund is rated Very High on the SEBI riskometer and belongs to the Sectoral-Pharma category.
Which fund house manages UTI Healthcare Fund?
UTI Healthcare Fund is managed by UTI Mutual Fund, which runs 67 schemes with ₹4,04,584 Cr under management.